
|Videos|October 11, 2016
Atopic Dermatitis: Cost and Value
Advertisement
Panelists Peter L. Salgo, MD; Cheryl Allen, BS Pharm, MBA; Jonathan Silverberg, MD, PhD, MPH; Ed Pezalla, MD, MPH; and Jeffrey D. Dunn, PharmD, MBA, provide insight on balancing the cost and benefit of treatments for atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Zongertinib Shows Clinically Meaningful Efficacy in Advanced HER2-Mutant NSCLC
2
Expert Discusses Logistical Considerations and Future Research Needs for Radiopharmaceuticals
3
A Common Virus May Hold New Clues to Lupus
4
SHR-A1811 Plus Pertuzumab Improves Survival in HER2-Positive Metastatic Breast Cancer
5















































































































































































































